The intraperitoneal injection of SR-8314 and SR-8291 led to increased frequencies of CD4 + and CD8 + T cells and resulted in a decrease in tumor-associated macrophages in tumor-bearing mice (Weston et al. 2019). The gene discussed is CD8A; the disease is neoplasm.